Brind.

Omnicell was classified into the Zacks Medical Info Systems industry.

2 reports, 2 independent Updated Jul 31
Gone quiet Reached 2 outlets in its first 24 hours
Reports
2
Developments
1
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Omnicell was classified into the Zacks Medical Info Systems industry.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

  • Omnicell

    American healthcare technology company

    Nothing else this week.

Related events

Coverage

Newest first; wire copies grouped
  • ZacksOmnicell (OMCL) Beats Q2 Earnings and Revenue Estimates Omnicell (OMCL) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to
  • StockStory3 Healthcare Stocks We Approach with Caution From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory